Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions
Episode Ep 136 10 min 33s

Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions

In this podcast episode, listen to Farrukh T. Awan, MD, and Nicole Lamanna, MD, answer questions from an audience of healthcare professionals on the evolving role of BTK inhibitors in CLL, including sequencing, combinations, and novel agents.

You May Also Like

Community discussion